These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37960717)

  • 21. Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial.
    Tepper SJ; Grosberg B; Daniel O; Kuruvilla DE; Vainstein G; Deutsch L; Sharon R
    Headache; 2022 Sep; 62(8):989-1001. PubMed ID: 35748757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
    Lipton RB; Stewart WF; Ryan RE; Saper J; Silberstein S; Sheftell F
    Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. a randomized controlled trial.
    Codispoti JR; Prior MJ; Fu M; Harte CM; Nelson EB
    Headache; 2001; 41(7):665-79. PubMed ID: 11554954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measures of Functioning in Patients With Episodic Migraine: Findings From a Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial With Galcanezumab.
    Ayer DW; Skljarevski V; Ford JH; Nyhuis AW; Lipton RB; Aurora SK
    Headache; 2018 Sep; 58(8):1225-1235. PubMed ID: 30106172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Long-term Effect of Acupuncture for Migraine Prophylaxis: A Randomized Clinical Trial.
    Zhao L; Chen J; Li Y; Sun X; Chang X; Zheng H; Gong B; Huang Y; Yang M; Wu X; Li X; Liang F
    JAMA Intern Med; 2017 Apr; 177(4):508-515. PubMed ID: 28241154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.
    Gelfand AA; Allen IE; Grimes B; Irwin S; Qubty W; Greene K; Waung M; Powers SW; Szperka CL
    Headache; 2023 Oct; 63(9):1314-1326. PubMed ID: 37466211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
    Reuter U; Goadsby PJ; Lanteri-Minet M; Wen S; Hours-Zesiger P; Ferrari MD; Klatt J
    Lancet; 2018 Nov; 392(10161):2280-2287. PubMed ID: 30360965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of topical Rose (Rosa damascena Mill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial.
    Niazi M; Hashempur MH; Taghizadeh M; Heydari M; Shariat A
    Complement Ther Med; 2017 Oct; 34():35-41. PubMed ID: 28917373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of green light exposure on headache frequency and quality of life in migraine patients: A preliminary one-way cross-over clinical trial.
    Martin LF; Patwardhan AM; Jain SV; Salloum MM; Freeman J; Khanna R; Gannala P; Goel V; Jones-MacFarland FN; Killgore WD; Porreca F; Ibrahim MM
    Cephalalgia; 2021 Feb; 41(2):135-147. PubMed ID: 32903062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acupuncture for acute migraine attacks in adults: a systematic review and meta-analysis.
    Wang Y; Du R; Cui H; Zhang L; Yuan H; Zheng S
    BMJ Evid Based Med; 2023 Aug; 28(4):228-240. PubMed ID: 37419658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
    Stauffer VL; Dodick DW; Zhang Q; Carter JN; Ailani J; Conley RR
    JAMA Neurol; 2018 Sep; 75(9):1080-1088. PubMed ID: 29813147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.
    Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N
    Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meditation for migraines: a pilot randomized controlled trial.
    Wells RE; Burch R; Paulsen RH; Wayne PM; Houle TT; Loder E
    Headache; 2014 Oct; 54(9):1484-95. PubMed ID: 25041058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater occipital nerve blockade for the preventive treatment of chronic migraine: A randomized double-blind placebo-controlled study.
    Chowdhury D; Tomar A; Deorari V; Duggal A; Krishnan A; Koul A
    Cephalalgia; 2023 Feb; 43(2):3331024221143541. PubMed ID: 36739512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial.
    Kumar A; Bhatia R; Sharma G; Dhanlika D; Vishnubhatla S; Singh RK; Dash D; Tripathi M; Srivastava MVP
    Neurology; 2020 May; 94(21):e2203-e2212. PubMed ID: 32376640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.
    Ashina M; Lanteri-Minet M; Pozo-Rosich P; Ettrup A; Christoffersen CL; Josiassen MK; Phul R; Sperling B
    Lancet Neurol; 2022 Jul; 21(7):597-607. PubMed ID: 35716692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial.
    Ramsden CE; Zamora D; Faurot KR; MacIntosh B; Horowitz M; Keyes GS; Yuan ZX; Miller V; Lynch C; Honvoh G; Park J; Levy R; Domenichiello AF; Johnston A; Majchrzak-Hong S; Hibbeln JR; Barrow DA; Loewke J; Davis JM; Mannes A; Palsson OS; Suchindran CM; Gaylord SA; Mann JD
    BMJ; 2021 Jun; 374():n1448. PubMed ID: 34526307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.